During the 1980, the haemophilia centre at the Royal Hospital for Sick Children ("RHSC") in Yorkhill, Glasgow, provided haemophilia treatment to children from the Glasgow area and across the West of Scotland. 55 had Haemophilia A, 14 had Haemophilia B and 1 had von Willebrand disease. Read more about During the 1980, the haemophilia centre at the Royal Hospital for Sick Children ("RHSC") in Yorkhill, Glasgow, provided haemophilia treatment to children from the Glasgow area and across the West of Scotland. 55 had Haemophilia A, 14 had Haemophilia B and 1 had von Willebrand disease.
In 1974 - 1975, at the Glasgow Royal Infirmary while commercial concentrates were in use cryoprecipitate was the predominant product. Read more about In 1974 - 1975, at the Glasgow Royal Infirmary while commercial concentrates were in use cryoprecipitate was the predominant product.
From 1980, when Professor Ludlam arrived in Edinburgh, the volume of NHS concentrates used exceeded the volume of cryoprecipitate for the first time. Read more about From 1980, when Professor Ludlam arrived in Edinburgh, the volume of NHS concentrates used exceeded the volume of cryoprecipitate for the first time.
In Edinburgh the principal product used in 1979 was cryoprecipitate. Read more about In Edinburgh the principal product used in 1979 was cryoprecipitate.
In Edinburgh the principal product used in 1978 was cryoprecipitate. Read more about In Edinburgh the principal product used in 1978 was cryoprecipitate.
In Edinburgh the principal product used in 1977 was cryoprecipitate. Read more about In Edinburgh the principal product used in 1977 was cryoprecipitate.
In Edinburgh the principal product used in 1976 was cryoprecipitate. Read more about In Edinburgh the principal product used in 1976 was cryoprecipitate.
Speakers from the Medical Ethics Experts Panel held that it was ethically wrong not to promptly provide patients with the outcomes of their diagnosis and test results. Read more about Speakers from the Medical Ethics Experts Panel held that it was ethically wrong not to promptly provide patients with the outcomes of their diagnosis and test results.
Speakers from the Medical Ethics Experts Panel held that it was ethically wrong not to explain the risks of treatment to patients. Read more about Speakers from the Medical Ethics Experts Panel held that it was ethically wrong not to explain the risks of treatment to patients.
Evidence presented to the inquiry held that while most doctors took the view that not discussing the risks associated with blood products with patients would not result in deterring patients from using the various treatments anyway. However, Professors Farsides and Kerridge on the medical experts panel to the inquiry disagreed, stating until one has disclosed all the risks to a patient, then one cannot assume patients are making a fully informed decision. Read more about Evidence presented to the inquiry held that while most doctors took the view that not discussing the risks associated with blood products with patients would not result in deterring patients from using the various treatments anyway. However, Professors Farsides and Kerridge on the medical experts panel to the inquiry disagreed, stating until one has disclosed all the risks to a patient, then one cannot assume patients are making a fully informed decision.